Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells

Cancer Detection and Prevention

Volumn 31, Issue 2, 2007, Pages 129-139

  Hostanska, Katarina ^a   Jürgenliemk, Guido ^b   Abel, Gudrun ^c   Nahrstedt, Adolf ^b   Saller, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Bionorica AG   (Germany)

Author keywords

Apoptosis; Cell growth assay; Cell lines; Cell viability; Colon cancer; Cyclooxygenase 2; Cytotoxicity; Growth inhibition; Lung cancer; Polyphenols; Salicin; Salix purpurea; Willow bark extract

Indexed keywords

ACETYLSALICYLIC ACID; BNO 1455; CYCLOOXYGENASE 2; FLAVANOID; LIPOCORTIN 5; PLANT EXTRACT; PROANTHOCYANIDIN DERIVATIVE; PROPIDIUM IODIDE; PROTEIN BCL 2; SALICIN; SALIGENIN; UNCLASSIFIED DRUG; WILLOW EXTRACT;

APOPTOSIS; ARTICLE; BARK; CALORIMETRY; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRUCTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIGHT SCATTERING; LUNG CANCER; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILLOW;

APOPTOSIS; CARCINOMA, SMALL CELL; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLAVONOIDS; FLOW CYTOMETRY; HT29 CELLS; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; PLANT BARK; PLANT EXTRACTS; PROANTHOCYANIDINS; SALICYLATES; SALIX; TUMOR CELLS, CULTURED;

EID: 34247590175     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.03.001     Document Type: Article

References (38)

1. Rao C.V., Newmark H.L., and Reddy B.S. Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detect Prev 26 (2002) 419-425
2. Zhang H., Spitz M.R., Tomlinson G.E., Schabath M.B., Minna J.D., and Wu X. Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Cancer Detect Prev 26 (2002) 4144-4418
3. Hedner T., and Everts B. The early clinical history of salicylates in rheumatology and pain. Clin Rheumatol 17 (1998) 17-25
4. Robbers J.E., Speedie M.K., and Tyler V.E. Pharmacognosy and pharmacobiotechnology (1996), Williams & Wilkins, Baltimore
5. Moysich K.B., Menezes R.J., Ronsani A., Swede H., Reid M.E., Cummings K.M., et al. Regular aspirin use and lung cancer risk. BMC Cancer 2 (2002) 31
6. Akhmedkhanov A., Toniolo P., Zeleniuch-Jacquotte A., Koenig K.L., and Shore R.E. Aspirin and lung cancer in women. Br J Cancer 87 (2002) 49-53
7. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 (1971) 232-235
8. Shiff S.J., Koutsos M., Qiao L., and Rigas B. Non-steroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 222 (1996) 179-188
9. Qiao L., Hanif R., Sphicas E., Shiff S.J., and Rigas B. Effect of aspirin on induction of apoptosis in HT 29 human colon adenocarcinoma cells. Biochem Pharmacol 55 (1998) 53-64
10. März R.W., and Kemper F. Willow bark extract-effects and effectiveness. Status of current knowledge regarding pharmacology, toxicology and clinical aspects. Wien Med Wochenschr 152 (2002) 354-359
11. Thieme H. On the tannin content of willow cortex. Pharmazie 23 (1968) 212-215
12. Meier B., Sticher O., and Julkunen-Tiitto R. Pharmaceutical aspects of the use of willows in herbal remedies. Planta Med 54 (1988) 559-560
13. Wagner I., Greim C., Laufer S., Heide L., and Gleiter C.H. Influence of willow bark extract on cyclooxygenase activity and on tumor necrosis factor alpha or interleukin 1 beta release in vitro and ex vivo. Clin Pharmacol Ther 73 (2003) 272-274
14. Albrecht M., Nahrstedt A., Laepke N.P., Theisen N.L., and Baron G. Anti-inflammatory activity of flavanol glycosides and salicin derivates from the leaves of Populus tremuloides. Planta Med 56 (1990) 660
15. Reed J.C. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 11 (1999) 68-75
16. Senderowicz A.M. Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol 16 (2004) 670-678
17. Taraphdar A.K., Madhumita R., and Bhattacharya R.K. Natural products as inducer of apoptosis: implication for cancer therapy and prevention. Curr Sci 11 (2001) 1387-1396
18. European Pharmacopeia (Ph Eur), 4th ed. Stuttgart: Deutscher Apotheker Verlag; 2002.
19. Glasl H. Zur Photometrie in der Drogenstandardisierung. DAZ 123 (1983) 1979-1987
20. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K., et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1 (1996) 1518-1520
21. Hostanska K., Hajto T., Fischer J., Mengs U., Weber K., Lentzen H., et al. Selective modulation of phosphatidylserine exposure on sub-populations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro. Cancer Detect Prev 23 (1999) 511-523
22. Kuntz S., Wenzel U., and Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38 (1999) 133-142
23. Agarwal C., Sharma Y., and Agarwal R. Anti-carcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU 145 cells: modulation of mitogenic signalling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinogen 28 (2000) 129-138
24. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2005) 401-409
25. Fiebich B.L., and Chrubasik S. Effects of an ethanolic Salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine 11 (2004) 135-138
26. Khayyal M.T., El-Ghazaly M.A., Abdallah D.M., Okpanyi S.N., Kelber O., and Weiser D. Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract. Arzneimittelforschung 55 (2005) 677-687
27. Green D.R., and Martin S.J. The killer and executioner: how apoptosis controls malignancy. Curr Opin Immunol 7 (1995) 694-703
28. Hida T., Leyton J., Makheja A.N., Ben-Av P., Hla T., Martinez A., et al. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res 18 (1998) 775-782
29. Hung W.C., and Chang H.C. Methanolic extract of adlay seed suppresses COX-2 expression of human lung cancer cells via inhibition of gene transcription. J Agric Food Chem 51 (2003) 7333-7337
30. Yoshimoto A., Kasahara K., Kawashima A., Fujimura M., and Nakao S. Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: a comparison with small lung cell cancer and correlation with angiogenesis, angiogenic factors and metastases. Oncol Rep 13 (2005) 1047-1057
31. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L., et al. Effect of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52 (1996) 237-245
32. Hostanska K., Vuong V., Rocha S., Soengas M.S., Glanzmann C., Saller R., et al. Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. Br J Cancer 88 (2003) 1785-1792
33. Swamy M.V., Herzog C.R., and Rao C.V. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Res 63 (2003) 5239-5242
34. Radhakrihsna Pillai G., Srivastava A.S., Hassanein T.I., Chauhan D.P., and Carrier E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208 (2004) 163-170
35. Zangemeister-Wittke U., Schenker T., Luedke G.H., and Stahel R.A. Synergistic cytotoxicity of Bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small cell lung cancer cell lines. Br J Cancer 78 (1998) 1035-1042
36. Reed J.C. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9 (1995) 451-473
37. Yu H.G., Huang J.A., Yang Y.N., Huang H., Luo H.S., Yu J.P., et al. The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. Eur J Clin Invest 32 (2002) 838-846
38. 2 in human colon cancer cells. Cancer Res 58 (1998) 362-366